CHRIS YAU CHUNG CHOI

Developed critical skills in fast-paced clinical environment, excelling in patient care and diagnostic procedures. Acquired expertise to collaborate effectively with other specialties to provide best medical care for patient. Seeking to transition into senior role by applying transferrable skills in dynamic and challenging setting.

• Age: 33
• Nationality: Chinese

1/2024 Fellow of the Hong Kong College of Physicians (Internal Medicine)

6/2023 Fellow of the Hong Kong Academy of Medicine in the specialty of Medicine

1/2023 Fellow of the Hong Kong College of Physicians (Infectious Disease)

2020 Member of the Royal Colleges of Physicians of the United Kingdom [MRCP(UK)]

2015 HKU MBBS

2024-25 Editor for KWC Antimicrobial Therapy Handbook 2025

2023 Speaker for Conjoint HAHO/ NTEC/ KWC Inter-Cluster Drill on Infectious Disease (Anthrax)

2023 Speaker for Post-registration Certificate Course (PRCC) in Advanced Medical Nursing (Management of Important Contemporary Emerging Infectious Disease + CPR ICT)

2022 Presentation in HKSID Annual Scientific Meeting (Kaposi Sarcoma)

2024 International Anal Neoplasia Society (IANS) Virtual Standard High Resolution Anoscopy Course

2023 Singapore Antimicrobial Stewardship Training Course (SASTC)

2021 Infectious Diseases in Adults by Harvard Medical School

2020-21 Infectious Disease Courses by Carol Yu Centre for Infection, The University of Hong Kong

• HIV medicine
• HIV-related malignancy (*High Resolution Anoscopy as standard of care for anal cancer screening)
• Antimicrobial Stewardship

Hospital Authority Outstanding Team Award - HAIDC 2022

LKS Faculty of Medicine The University of Hong Kong Faculty Outstanding Research Output Award - 2020-21

• Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study., The Lancet Infectious Diseases
• Boosting of serum neutralizing activity against the Omicron variant among recovered COVID-19 patients by BNT162b2 and CoronaVac vaccines., EBioMedicine
• Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections., Cell Reports